Showing 113–120 of 120 results
-

20mgHPLC99.287%
$130
Vesilute is a synthetic bioactive peptide belonging to the Havensone peptide family, featuring a core amino acid sequence of Glu-Asp. It exerts regulatory effects on urinary system tissues like the bladder and prostate by influencing cellular gene expression to modulate physiological functions in these tissues.
View COA (Certificate of Analysis)
-

20mgHPLC99.291%
$125
Vesugen is a synthetic peptide composed of a specific amino acid sequence, which has the function of regulating various physiological processes in organisms. It exerts its biological effects by binding to specific targets within cells, influencing gene expression and cellular metabolism.
View COA (Certificate of Analysis)
-

20mgHPLC99.630%
$130
Vilon, a dipeptide composed of lysine and glutamic acid, exhibits multifaceted effects. In anti-aging, it delays cellular aging by improving gastrointestinal function, enhancing enzyme activity, and promoting nutrient absorption. It also boosts collagen expression in the skin to reduce signs of aging. In tissue repair and regeneration, Vilon supports stem cell activation and proliferation, accelerates wound healing, and aids in tissue repair (e.g., skin and intestinal tissues) by regulating fibroblast activity. Beneficial for cardiovascular and renal health, it improves cardiovascular function and regulates microvascular permeability in renal diseases. Additionally, Vilon shows potential applications in adjuvant therapy for liver diseases, diabetes, and radiation injuries, as well as in regulating overall bodily functions.
View COA (Certificate of Analysis)
-

10mgHPLC99.291%
$175
VIP (Vasoactive Intestinal Peptide) is an acidic polypeptide neurotransmitter composed of 28 amino acid residues, belonging to the vasoactive intestinal peptide/glucagon-like peptide family. Primarily synthesized and secreted by the central nervous system, gastrointestinal ganglia, and immune cells, it diffuses to target cells via blood or interstitial fluid. By binding to specific receptors, it exerts physiological effects crucial for vascular regulation, gastrointestinal function control, immune homeostasis, and neuroprotection.
View COA (Certificate of Analysis)
-

6mgHPLC99.827%
$130
VIP (Vasoactive Intestinal Peptide) is an acidic polypeptide neurotransmitter composed of 28 amino acid residues, belonging to the vasoactive intestinal peptide/glucagon-like peptide family. Primarily synthesized and secreted by the central nervous system, gastrointestinal ganglia, and immune cells, it diffuses to target cells via blood or interstitial fluid. By binding to specific receptors, it exerts physiological effects crucial for vascular regulation, gastrointestinal function control, immune homeostasis, and neuroprotection.
View COA (Certificate of Analysis)
-

5mgHPLC99.612%
$43
Retatrutide is a novel peptide-based drug that functions as a triple receptor agonist, simultaneously targeting GLP-1, GIP, and glucagon receptors. It facilitates weight loss through comprehensive regulation of appetite by enhancing satiety, suppressing hunger, and increasing energy expenditure. Additionally, Retatrutide demonstrates significant improvements in multiple cardiometabolic risk indicators including blood pressure, glycated hemoglobin (HbA1c), fasting blood glucose, insulin levels, total cholesterol, LDL cholesterol, and triglycerides. It also exerts positive effects on patients with non-alcoholic fatty liver disease (NAFLD), normalizing hepatic fat content in the majority of participants.
View COA (Certificate of Analysis)
-

15mgHPLC99.427%
$84
Retatrutide is a novel peptide-based drug that functions as a triple receptor agonist, simultaneously targeting GLP-1, GIP, and glucagon receptors. It facilitates weight loss through comprehensive regulation of appetite by enhancing satiety, suppressing hunger, and increasing energy expenditure. Additionally, Retatrutide demonstrates significant improvements in multiple cardiometabolic risk indicators including blood pressure, glycated hemoglobin (HbA1c), fasting blood glucose, insulin levels, total cholesterol, LDL cholesterol, and triglycerides. It also exerts positive effects on patients with non-alcoholic fatty liver disease (NAFLD), normalizing hepatic fat content in the majority of participants.
View COA (Certificate of Analysis)
-

60mgHPLC99.543%
$253
Retatrutide is a novel peptide-based drug that functions as a triple receptor agonist, simultaneously targeting GLP-1, GIP, and glucagon receptors. It facilitates weight loss through comprehensive regulation of appetite by enhancing satiety, suppressing hunger, and increasing energy expenditure. Additionally, Retatrutide demonstrates significant improvements in multiple cardiometabolic risk indicators including blood pressure, glycated hemoglobin (HbA1c), fasting blood glucose, insulin levels, total cholesterol, LDL cholesterol, and triglycerides. It also exerts positive effects on patients with non-alcoholic fatty liver disease (NAFLD), normalizing hepatic fat content in the majority of participants.
View COA (Certificate of Analysis)